Early studies in humans have shown that insulin-stimulated vasodilation could be a significant contributor to insulin-stimulated glucose uptake [103] by a mechanism involving eNOS, which can be impaired in people with obesity or type 2 diabetes [104]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.